Mobile and health technologies are converging into digital health gadgets but will consumers embrace these gadgets ?
Via Philippe Marchal, Giuseppe Fattori
Une veille sur la santé numérique en France et à l’international : politiques publiques, données, infrastructures, IA, services et usages. Études, rapports et retours de terrain sélectionnés par Lionel Reichardt, Pharmageek, pour comprendre les transformations et éclairer les décisions.
Your new post is loading...
Your new post is loading...
Mobile and health technologies are converging into digital health gadgets but will consumers embrace these gadgets ? Via Philippe Marchal, Giuseppe Fattori No comment yet.
Sign up to comment
By Michelle McNickle New mobile apps from the Department of Health and Human Services, for consumers and doctors alike, let you search medical literature, locate health centers, fight drug abuse and much more. Health Apps Set to Explode in 2013 Will 2013 be the year of the mobile app? Pundits seem to think so, and the prediction holds true for healthcare professionals and consumers alike. Although developers have come up with several apps to help clinicians diagnose and manage disease, the use of medical apps among consumers is set to take center stage, especially in light of new patient engagement requirements that are part of the government's Meaningful Use Stage 2 program. Via rob halkes
rob halkes's curator insight,
January 10, 2013 1:32 AM
Imho health apps have already exploded in front of us. I guess it will be difficult for patients with specific conditions to find the right support to their choice. You might want to try for instance loooking for an app support in coping with your snoring condition. What you get as a "lay" patient looks like chaos and I could imagine you would turn right away when confronted. .. It means that health care is a co-creating ambition: integrated and coordinated support is needed. The formal systems need to go a long road still to create this condition for patients to find their way easily to reliable, informed and cooperative health care support. But it is needed and there is no other way than to try and build it. Apps might help us to move into that direction quicker!
La recherche d’information santé sur internet est depuis plusieurs années, en tête de liste des thèmes pour les requêtes sur les moteurs de recherche. Forts de ce constat, bon nombre d’acteurs se sont positionnés sur ce créneau de la dispensation d’information santé, notamment pour le grand public. Et parmi ces acteurs historiques, l’industrie pharmaceutique est présente via des sites d’informations grand public autour de pathologies. Via Alexandre DUBOIS
Which Docs Prescribe More Expensive Meds? http://t.co/D04aFgwE
This is an interview with digital health expert, Chris Boyer, about the most useful socia media channels, including Facebook, Twitter and YouTube.
Just a few more left in our Best of 2012 series! This week we’re looking at some of the top articles for Health Gamification in 2012. We’re looking at a number of awesome little devices and programs to educate, assist, and protect the ill as well as those practicing medicine. Remember that the gamification health need not only apply to the sick; it is just as helpful for medical practitioners as well. It would seem that a number of the most popular articles were related to pediatric gamification, or simply, gamification targeted at children’s health. Via Alex Butler
With hundreds of medications approved annually coupled with patent expiration, medications going generic and the plight of drug shortages, pharmacists are expected to know everything ranging from alternatives, doses, contraindications and drug... Via Emmanuel Capitaine
Selon l'Assurance maladie, les dépenses du régime général augmentent de + 2,1 % sur les onze premiers mois de l’année 2012 et les remboursements de soins de ville du régime gé (Dépenses de remboursements de médicaments : -1,5 % sur les... Via Xavier Bouhet
The absence of digital health companies on the agenda of a major healthcare industry conference points to a significant opportunity for future healthcare entrepreneurs and investors. Via Dan Baxter
Lionel Reichardt / le Pharmageek's insight:
'For all the interest in wellness apps and engaging gadgets, here is where the money is – or at least a lot of it. It’s in payors trying to assess value, medical product companies trying to create it, and healthcare systems trying to deliver it.' <Think that sum's it up pretty nicely.
Dan Baxter's curator insight,
January 7, 2013 4:37 PM
'For all the interest in wellness apps and engaging gadgets, here is where the money is – or at least a lot of it. It’s in payors trying to assess value, medical product companies trying to create it, and healthcare systems trying to deliver it.' <Think that sum's it up pretty nicely.
GlaxoSmithKline has formed a partnership with Vodafone to use mobile technology to help vaccinate more children against common infectious diseases in Africa.
Lionel Reichardt / le Pharmageek's insight:
Mothers and caregivers alike shall be alerted by the use of SMS about availability of vaccinations. The database created by the scheme can also schedule appointments via SMS and notifications will help to ensure that children complete the full schedule of vaccinations.
Health workers will be given smartphones with software that allows them to contact mothers, view and record vaccination histories, schedule vaccinations and report on follow-up visits. For supply-chain management, healthcare facilities will be prompted to report on vaccine stock levels by SMS.
Pharmacomptoir / Corinne Thuderoz's curator insight,
January 8, 2013 2:47 PM
Mothers and caregivers alike shall be alerted by the use of SMS about availability of vaccinations. The database created by the scheme can also schedule appointments via SMS and notifications will help to ensure that children complete the full schedule of vaccinations.
Health workers will be given smartphones with software that allows them to contact mothers, view and record vaccination histories, schedule vaccinations and report on follow-up visits. For supply-chain management, healthcare facilities will be prompted to report on vaccine stock levels by SMS.
Pharmaceutical companies are starting to look beyond recession and investing in innovation again. Many are expanding their international customer excellence teams or even appointing a Global or Re...
Lionel Reichardt / le Pharmageek's insight:
Solid understanding of what really matters here. Can't agree more with Kay's resolutions. The word "platform" however stikes an alien ring of IT in the hearts of most "business" focused folks. We have the feeling that it will turn into another 2 year project where reams of consultants will arrive to train the whole organisation on how to use a complex tool, taking us away from focusing on the business. Truth is it doesn't have to be like that (the old days of SAP and Siebel roll-outs should be over!). Yes, there are new learnings that must be integrated, but the world is moving forward, so stop sticking your heads in the sand and get on with it. Most learning on platforms should be either self explaining, or very easy "self-help" modules. If it isn't ask why not! The issue of investment raised in the article underlies a real issue in Pharma - we simply do not invest enough to achieve the goals set out. We're setting ourselves up for failure! These investments are not only in the "platforms", but also the time & effort investment on getting the "processes" right. I'm looking forward to hear Kay's insights on that too! |
Slightly more than 21% of U.S. adults ages 18 to 24 follow a health care provider on Facebook, Twitter or another social media website, while only 3% of U.S. Via BlablaDoctor
Statistics on mobile usage and adoption to inform your mobile marketing strategy Via Emmanuel Capitaine
Public mind map by vezin fabrice. Create your own collaborative mind maps for free at www.mindmeister.com
Selon une étude américaine du Centre de recherche Pew Internet (Mobile Health 2012), la moitié des personnes qui possèdent un téléphone intelligent l’utilisent pour rechercher de l’information sur la santé. Via Emmanuel Capitaine
Your competitors are quietly using physician liaisons to win your doctor referrals. It’s time to have your own reps in this increasingly competitive environment.
Les Échos
According to Rock Health, a San Francisco-based accelerator, digital health start-ups raised a record $1.4 billion last year, a 45% increase over 2011.
Le monde de la santé a entamé ces dernières années une profonde mutation poussée par l’essor des nouvelles technologies… la médecine de demain, où plutôt celle qui se dessine aujourd’hui, est une médecine de réseaux, dans laquelle la gestion de l’information est un enjeu majeur. L’e-santé émerge et avec elle des solutions qui modifient déjà la pratique des professionnels de santé mais également le parcours des patients dans le système de soin.
Via Bérénice LOUIS
par Olivier Milcent (@omilcent), DG France et CMO de Momac Le webdesign est entré dans une nouvelle ère, celle du multiscreen. Via Herman vincent / My Check Experience
Here is a graphic I use all the time to describe the consumer decision journey (CDJ). I like to say that the funnel is dead, because it’s outdated. Today’s consumer takes a much more (RT @fluffylinks: The funnel is dead. Via Gilles Jourquin, Dan Baxter
Lionel Reichardt / le Pharmageek's insight:
Goodbye to the funnel!
Lionel Reichardt / le Pharmageek's insight:
Those who are immersed in tracking the pharmaceutical industry are well aware that getting new medicines to market has become increasingly challenging. But what happens after FDA approval? The product launch. But this process has also become a minefield of new obstacles that require a degree of rethinking and maneuvering. And so, we asked Peter Hansen (that’s him on the right), who is the senior manager and global product launch lead for the Accenture Life Sciences industry practice, to explain what drugmakers need to know and do if they want to bring a medicine not just from the lab to FDA offices, but also into patient hands…
Richard Meyer's curator insight,
January 8, 2013 9:05 AM
Those who are immersed in tracking the pharmaceutical industry are well aware that getting new medicines to market has become increasingly challenging. But what happens after FDA approval? The product launch. But this process has also become a minefield of new obstacles that require a degree of rethinking and maneuvering. And so, we asked Peter Hansen (that’s him on the right), who is the senior manager and global product launch lead for the Accenture Life Sciences industry practice, to explain what drugmakers need to know and do if they want to bring a medicine not just from the lab to FDA offices, but also into patient hands… |
Your new post is loading...